DTRT Health Acquisition Corp. Unit
DTRTU
DTRTU was delisted on the 26th of January, 2023.
2 hedge funds and large institutions have $20.1K invested in DTRT Health Acquisition Corp. Unit in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 11 closing their positions.
85% less funds holding
Funds holding: 13 → 2 (-11)
100% less capital invested
Capital invested by funds: $6.2M → $20.1K (-$6.18M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 11
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$2.06M |
| 2 |
Walleye Capital
New York
|
-$1.04M |
| 3 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
-$1.02M |
| 4 |
WC
Wealthspring Capital
West Harrison,
New York
|
-$559K |
| 5 |
Walleye Trading
New York
|
-$553K |
DTRTU Hedge Fund Activity: Q4 2022 in Review
2 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in DTRT Health Acquisition Corp. Unit (DTRTU) for Q4 2022, worth a combined $20.1K — down 100% from $6.2M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of DTRTU and 0 opened new positions — a net loss of 11 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Landscape Capital Management, exiting entirely with an estimated $2.06M sold.
- 2 institutional investors held DTRT Health Acquisition Corp. Unit (DTRTU) as of Q4 2022, down from 13 in Q3 2022.
- Funds reported $20.1K of DTRT Health Acquisition Corp. Unit stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new DTRT Health Acquisition Corp. Unit positions in Q4 2022 and 11 closed out, a net change of -11 holders.
- The largest DTRT Health Acquisition Corp. Unit seller in Q4 2022 was Landscape Capital Management, an estimated $2.06M sold.
Based on aggregated 13F filings for Q4 2022.